EUVIMEDEUVIMED entdecken
Crossref

TPTh 5.17 Comparative Study of Plain Balloon versus Drug-coated Balloon for Angioplasty of Dysfunctional Autogenous Arteriovenous Fistula

Sherif Hassan, Ashraf El Attar, Ahmed El-Barbary, AbdelRahman Nagy

British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)

DOI: 10.1093/bjs/znag087.481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von Sherif Hassan und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to compare efficacy and safety of drug-coated balloon angioplasty (DCB) versus plain balloon angioplasty (PBA) in treating dysfunctional arteriovenous fistulas (AVFs) among end-stage renal disease (ESRD) patients. Primary endpoints were target lesion primary patency (TLPP) and secondary patency (TLSP), while secondary endpoints included adverse events and patency predictors. Patients and methods A prospective comparative study was conducted over 1 year, including 30 patients with dysfunctional AVFs, divided into two groups: DCB (n=11) and PBA (n=19). Inclusion criteria involved mature AVFs with >50% stenosis and clinical dysfunction. Exclusion criteria included total thrombosis, infection, and contraindications to contrast media or paclitaxel.

Results

At 6 months, TLPP was 72.7% for DCB and 78.9% for PBA (P 0.70), while at 1 year, TLPP was 63.6% for DCB and 55.6% for PBA (P 0.69). TLSP at 6 months was 90.9% for DCB and 89.5% for PBA (P 0.90), and at 1 year, it was 90.9% for DCB and 83.3% for PBA (P 0.57). Restenosis rates at 1 year were 36.4% for DCB and 42.1% for PBA (P 0.76). No significant predictors of TLPP were identified. Adverse events were minimal, one case of AVF rupture in PBA group and no procedure-related mortality.

Conclusion

Both TLPP and TLSP were comparable in studied groups with no significant advantage of either group regarding safety or efficacy. While DCB may offer short-term benefits, more extended workup is needed to establish its long-term advantages over PBA in maintaining AVF health and functionality.

Zitieren

APA

Hassan, S., Attar, A. E., El-Barbary, A., & Nagy, A. (2026). TPTh 5.17 Comparative Study of Plain Balloon versus Drug-coated Balloon for Angioplasty of Dysfunctional Autogenous Arteriovenous Fistula. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.481

Vancouver

Hassan S, Attar AE, El-Barbary A, Nagy A. TPTh 5.17 Comparative Study of Plain Balloon versus Drug-coated Balloon for Angioplasty of Dysfunctional Autogenous Arteriovenous Fistula. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.481

BibTeX
@article{Hassan2026,
  author = {Hassan, Sherif and Attar, Ashraf El and El-Barbary, Ahmed and Nagy, AbdelRahman},
  title = {TPTh 5.17 Comparative Study of Plain Balloon versus Drug-coated Balloon for Angioplasty of Dysfunctional Autogenous Arteriovenous Fistula},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_8},
  doi = {10.1093/bjs/znag087.481}
}
Kostenlos starten →